Defeat Cancer by Detecting it Early
EarlyDiagnostics (EarlyDx) is devoted to providing accurate, affordable, and non-invasive liquid biopsy tests for early cancer detection and precision medicine.
About
Big Data for Better Diagnosis
We have developed a blood test, CancerRadar, which is highly accurate and sensitive in detecting and locating cancer. In addition, we developed a One-Stop Shop bioinformatics solution, EarlyDx-Cloud, to help many diagnostic companies offer liquid biopsy tests for cancer detection, therapy selection, and treatment monitoring.
how it works
The Technology behind Cancer Detection
Discover our experimental and computational innovations.
CancerRadar
CancerRadar is a blood test, which is highly sensitive in detecting a trace amount of tumor DNA in cell-free DNAs.
Cloud Platform
EarlyDx-Cloud is a cloud-based platform for integrative bioinformatics analysis.
Publications
Our technologies are empowered by Innovation.
Our Team
Our Experts Are Waiting For You
We bring the right people together to challenge established thinking and drive transformation.
Latest News
Read the latest news and blog posts from EarlyDx.
April 2021
Co-founder Jasmine Zhou to Report EarlyDx’s CancerRadar Technology and Clinical Data in Oral Presentation at AACR Annual Meeting 2021 on April 10, 2021.
May 2020
EarlyDx Awarded an NIH SBIR Phase I Grant for Assay Development.